Standard
Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes. / Janaszewska, Anna; Gorzkiewicz, Michal; Ficker, Mario; Petersen, Johannes Fabritius; Paolucci, Valentina; Christensen, Jørn Bolstad; Klajnert-Maculewicz, Barbara.
I:
Molecular Pharmaceutics, Bind 15, Nr. 1, 2018, s. 12-20.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Janaszewska, A, Gorzkiewicz, M, Ficker, M, Petersen, JF, Paolucci, V
, Christensen, JB & Klajnert-Maculewicz, B 2018, '
Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes',
Molecular Pharmaceutics, bind 15, nr. 1, s. 12-20.
https://doi.org/10.1021/acs.molpharmaceut.7b00515APA
Janaszewska, A., Gorzkiewicz, M., Ficker, M., Petersen, J. F., Paolucci, V.
, Christensen, J. B., & Klajnert-Maculewicz, B. (2018).
Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes.
Molecular Pharmaceutics,
15(1), 12-20.
https://doi.org/10.1021/acs.molpharmaceut.7b00515Vancouver
Janaszewska A, Gorzkiewicz M, Ficker M, Petersen JF, Paolucci V
, Christensen JB o.a.
Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes.
Molecular Pharmaceutics. 2018;15(1):12-20.
https://doi.org/10.1021/acs.molpharmaceut.7b00515Author
Janaszewska, Anna ; Gorzkiewicz, Michal ; Ficker, Mario ; Petersen, Johannes Fabritius ; Paolucci, Valentina ; Christensen, Jørn Bolstad ; Klajnert-Maculewicz, Barbara. / Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes. I: Molecular Pharmaceutics. 2018 ; Bind 15, Nr. 1. s. 12-20.
Bibtex
@article{facfa13a1d53453f80c7b262a4a011f4,
title = "Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes",
keywords = "PAMAM dendrimer, pyrrolidone, inflammation, NF-kappa B, biocompatibility",
author = "Anna Janaszewska and Michal Gorzkiewicz and Mario Ficker and Petersen, {Johannes Fabritius} and Valentina Paolucci and Christensen, {J{\o}rn Bolstad} and Barbara Klajnert-Maculewicz",
year = "2018",
doi = "10.1021/acs.molpharmaceut.7b00515",
language = "English",
volume = "15",
pages = "12--20",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "1",
}
RIS
TY - JOUR
T1 - Pyrrolidone Modification Prevents PAMAM Dendrimers from Activation of Pro-Inflammatory Signaling Pathways in Human Monocytes
AU - Janaszewska, Anna
AU - Gorzkiewicz, Michal
AU - Ficker, Mario
AU - Petersen, Johannes Fabritius
AU - Paolucci, Valentina
AU - Christensen, Jørn Bolstad
AU - Klajnert-Maculewicz, Barbara
PY - 2018
Y1 - 2018
KW - PAMAM dendrimer
KW - pyrrolidone
KW - inflammation
KW - NF-kappa B
KW - biocompatibility
U2 - 10.1021/acs.molpharmaceut.7b00515
DO - 10.1021/acs.molpharmaceut.7b00515
M3 - Journal article
C2 - 29191014
VL - 15
SP - 12
EP - 20
JO - Molecular Pharmaceutics
JF - Molecular Pharmaceutics
SN - 1543-8384
IS - 1
ER -
